Study to Evaluate a New Treatment For Pancreas Cancer Patients (A021101)

What we are studying

The purpose of this study is to evaluate a new treatment program for patients with borderline resectable pancreas cancer. We want to find out what effects, good and bad, chemotherapy and chemoradiation have on your cancer and to see if it allows safe surgery. The standard of care treatment is combination with chemotherapy ( capecitabine or 5FU or gemcitabine) with radiation.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Pancreas Cancer (type = adenocarcinoma) No metastatic disease No prior chemotherapy or radiation

What is involved

  • Physical Exam
  • Blood tests
  • CT scan or MRI of the chest and abdomen
  • Chemotherapy and radiation before surgery
  • Additional chemotherapy after surgery

Compensation

None

Contact Information

Study Coordinator
Stacey Lewis, RN
Email
stalewis@wakehealth.edu
Phone
336-713-6927

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.